BACKGROUND: Separately, prenatal antibiotics and Caesarian delivery have been found to be associated with increased risk of allergic diseases. It is not clear whether these factors may modify the effect of each other. OBJECTIVE: To assess whether the associations between delivery types and eczema, sensitization and total IgE at age 2 years were modified by maternal use of prenatal medications. METHODS: Prenatal charts of women enrolled in the WHEALS birth cohort were reviewed for delivery mode and medications prescribed and administered throughout their entire pregnancy, including systemic antibiotics and vaginally applied antifungal medications. The associations between the delivery mode and select medications and, eczema, sensitization (≥ 1 of 10 allergen-specific IgE ≥ 0.35 IU/mL) and total IgE at age 2 years were assessed. RESULTS: There was a lower risk of eczema among vaginally vs. c-section born children (relative risk adjusted for race = aRR = 0.77, 95% CI 0.56, 1.05). Although not statistically significantly different, this association was stronger among the subset of children born vaginally to a mother who did not use systemic antibiotics or vaginal antifungal medications (aRR = 0.69, 95% CI 0.44, 1.08) compared to those born vaginally to mothers who used systemic antibiotics or vaginal antifungals (aRR = 0.81, 95% CI 0.57, 1.14). A protective association between vaginal birth and sensitization (aRR = 0.86, 95% CI 0.72, 1.03) was similar for those children born vaginally to a mother who did not (aRR = 0.87, 95% CI 0.69, 1.10) and who did (RR = 0.85, 95% CI 0.70, 1.04) use systemic antibiotics or vaginal antifungal medications. There were no associations with total IgE. CONCLUSIONS: Children born vaginally had lower risk of eczema and sensitization compared with those born via c-section; however, the protective association with eczema may be slightly weakened when mothers took systemic antibiotics or vaginally applied medications during pregnancy.
BACKGROUND: Separately, prenatal antibiotics and Caesarian delivery have been found to be associated with increased risk of allergic diseases. It is not clear whether these factors may modify the effect of each other. OBJECTIVE: To assess whether the associations between delivery types and eczema, sensitization and total IgE at age 2 years were modified by maternal use of prenatal medications. METHODS: Prenatal charts of women enrolled in the WHEALS birth cohort were reviewed for delivery mode and medications prescribed and administered throughout their entire pregnancy, including systemic antibiotics and vaginally applied antifungal medications. The associations between the delivery mode and select medications and, eczema, sensitization (≥ 1 of 10 allergen-specific IgE ≥ 0.35 IU/mL) and total IgE at age 2 years were assessed. RESULTS: There was a lower risk of eczema among vaginally vs. c-section born children (relative risk adjusted for race = aRR = 0.77, 95% CI 0.56, 1.05). Although not statistically significantly different, this association was stronger among the subset of children born vaginally to a mother who did not use systemic antibiotics or vaginal antifungal medications (aRR = 0.69, 95% CI 0.44, 1.08) compared to those born vaginally to mothers who used systemic antibiotics or vaginal antifungals (aRR = 0.81, 95% CI 0.57, 1.14). A protective association between vaginal birth and sensitization (aRR = 0.86, 95% CI 0.72, 1.03) was similar for those children born vaginally to a mother who did not (aRR = 0.87, 95% CI 0.69, 1.10) and who did (RR = 0.85, 95% CI 0.70, 1.04) use systemic antibiotics or vaginal antifungal medications. There were no associations with total IgE. CONCLUSIONS:Children born vaginally had lower risk of eczema and sensitization compared with those born via c-section; however, the protective association with eczema may be slightly weakened when mothers took systemic antibiotics or vaginally applied medications during pregnancy.
Authors: Frederika A van Nimwegen; John Penders; Ellen E Stobberingh; Dirkje S Postma; Gerard H Koppelman; Marjan Kerkhof; Naomi E Reijmerink; Edward Dompeling; Piet A van den Brandt; Isabel Ferreira; Monique Mommers; Carel Thijs Journal: J Allergy Clin Immunol Date: 2011-08-27 Impact factor: 10.793
Authors: Hedvig E Jakobsson; Thomas R Abrahamsson; Maria C Jenmalm; Keith Harris; Christopher Quince; Cecilia Jernberg; Bengt Björkstén; Lars Engstrand; Anders F Andersson Journal: Gut Date: 2013-08-07 Impact factor: 23.059
Authors: Intan H Ismail; Frances Oppedisano; Shayne J Joseph; Robert J Boyle; Paul V Licciardi; Roy M Robins-Browne; Mimi L K Tang Journal: Pediatr Allergy Immunol Date: 2012-07-26 Impact factor: 6.377
Authors: Jakob Stokholm; Susanne Schjørring; Louise Pedersen; Anne Louise Bischoff; Nilofar Følsgaard; Charlotte G Carson; Bo Chawes; Klaus Bønnelykke; Anne Mølgaard; Karen A Krogfelt; Hans Bisgaard Journal: PLoS One Date: 2012-09-25 Impact factor: 3.240
Authors: A E Cassidy-Bushrow; C Burmeister; S Havstad; A M Levin; S V Lynch; D R Ownby; A G Rundle; K J Woodcroft; E M Zoratti; C C Johnson; G Wegienka Journal: Int J Obes (Lond) Date: 2017-08-17 Impact factor: 5.095
Authors: Michael D Cabana; Michelle McKean; Aaron B Caughey; Lawrence Fong; Susan Lynch; Angela Wong; Russell Leong; Homer A Boushey; Joan F Hilton Journal: Pediatrics Date: 2017-08-07 Impact factor: 7.124
Authors: Sophia R Levan; Kelsey A Stamnes; Din L Lin; Ariane R Panzer; Elle Fukui; Kathryn McCauley; Kei E Fujimura; Michelle McKean; Dennis R Ownby; Edward M Zoratti; Homer A Boushey; Michael D Cabana; Christine C Johnson; Susan V Lynch Journal: Nat Microbiol Date: 2019-07-22 Impact factor: 17.745
Authors: Ganesa Wegienka; Alexandra Sitarik; Albert M Levin; Edward M Zoratti; Dennis Ownby; Christine Cole Johnson; Suzanne Havstad Journal: Ann Allergy Asthma Immunol Date: 2019-04-04 Impact factor: 6.347
Authors: M O Coker; A G Hoen; E Dade; S Lundgren; Z Li; A D Wong; M S Zens; T J Palys; H G Morrison; M L Sogin; E R Baker; M R Karagas; J C Madan Journal: BJOG Date: 2019-06-05 Impact factor: 6.531
Authors: A E Cassidy-Bushrow; A Sitarik; A M Levin; S V Lynch; S Havstad; D R Ownby; C C Johnson; G Wegienka Journal: J Dev Orig Health Dis Date: 2015-08-12 Impact factor: 2.401
Authors: Andrea E Cassidy-Bushrow; Alexandra R Sitarik; Suzanne Havstad; Sung Kyun Park; Lawrence F Bielak; Christine Austin; Christine Cole Johnson; Manish Arora Journal: Environ Int Date: 2017-09-05 Impact factor: 9.621
Authors: Jennifer K Straughen; Alexandra R Sitarik; Christine Cole Johnson; Ganesa Wegienka; Dennis R Ownby; Tisa M Johnson-Hooper; Ghassan Allo; Albert M Levin; Andrea E Cassidy-Bushrow Journal: Front Pediatr Date: 2021-05-14 Impact factor: 3.418
Authors: Christophe Lay; Collins Wenhan Chu; Rikky Wenang Purbojati; Enzo Acerbi; Daniela I Drautz-Moses; Paola Florez de Sessions; Song Jie; Eliza Ho; Yee Jiun Kok; Xuezhi Bi; Shuwen Chen; Shi Ya Mak; Mei Chien Chua; Anne E N Goh; Wen Chin Chiang; Rajeshwar Rao; Surasith Chaithongwongwatthana; Nipon Khemapech; Voranush Chongsrisawat; Rocio Martin; Guus Roeselers; Ying Swan Ho; Martin L Hibberd; Stephan C Schuster; Jan Knol Journal: BMC Microbiol Date: 2021-06-25 Impact factor: 3.605